News

Newly Approved Prostate Cancer Scan Can Detect Cells that Have Spread to Lymph Nodes

A revolutionary new diagnostic method for prostate cancer can detect prostate cancer cells that have spread to lymph nodes both inside and outside the pelvis, according to the UC San Francisco and UCLA team whose earlier work led to the test’s FDA approval. The test, which is now available at UCSF

Looking Beyond DNA to See Cancer with New Clarity

Researchers at UC San Francisco and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments that may avoid the side effects

UCSF and Northwestern Awarded $4.2M to Advance Glioblastoma Therapeutics

Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed. In response, the National Cancer Institute (NCI) has established the Glioblastoma Therapeutics Network (GTN

An Estrogen Receptor that Promotes Cancer also Causes Drug Resistance

Cancer cells proliferate despite a myriad of stresses – from oxygen deprivation to chemotherapy – that would kill any ordinary cell. Now, researchers at UC San Francisco have gained insight into how they may be doing this through the downstream activity of a powerful estrogen receptor. The discovery

HDFCCC Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

Cancer Center BOP Members May Boycott Conference over Texas Abortion Law

In response to the recent adoption of the Texas Heartbeat Act (SB8) banning nearly all abortions, the Cancer Center’s Breast Oncology Program members are part of a growing effort to move the annual San Antonio Breast Cancer Symposium (SABCS) out of Texas. The new law, which bans abortions after six

Ana Velázquez Mañana, MD, ASCO Mentor for Oncology Student Diversity